Summary:
- Researchers at Lawrence Berkeley National Laboratory have developed a new technique to improve the precision of targeted cancer therapies using advanced molecular imaging and radiopharmaceuticals.
- The study focuses on optimizing the delivery of therapeutic isotopes to tumor sites while minimizing radiation exposure to surrounding healthy tissues, potentially reducing side effects for patients.